Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DN7H3D
|
|||
| Drug Name |
BNT163
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Herpes simplex infection [ICD-11: 1F00] | Phase 1 | [1] | |
| Company |
BioNTech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05432583) Phase I, Randomized, Observer-blinded, Placebo-controlled, 2-part, Dose Escalation and Expanded Safety Evaluation Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Prophylactic Vaccine for the Prevention of Genital Lesions Caused by Herpes Simplex Virus (HSV)-2 and Potentially HSV-1. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.